A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft

Overview

The purpose of this study is to evaluate the comfort of BEPREVE compared to LASTACAFT after instillation.

Full Title of Study: “A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft in Patients With a History of Allergic Conjunctivitis”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: May 2011

Detailed Description

After one drop is instilled subjects will complete a comfort assessment at 1, 3, 5, and 10 minutes after drop instillation.

Arms, Groups and Cohorts

  • Bepreve
    • Subjects with a history of allergic conjunctivitis.
  • Lastacaft
    • Subjects with a history of allergic conjunctivitis.

Participating in This Clinical Trial

Inclusion Criteria

Each patient must meet the following criteria to be enrolled in this study: 1. Are male or female at least 18 years of age who are diagnosed with allergic conjunctivitis. 2. Have allergic ocular symptoms within the last three days. 3. Are willing/able to follow instructions from the study investigator and his/her staff. 4. Have signed informed consent approved by Institutional Review Board or Independent Ethics Committee. Exclusion Criteria:

Patients who meet any of the following criteria will be excluded from the study: 1. Have known hypersensitivity to either BEPREVE™ or LASTACAFT® or to any component of the test article (including "procedural" medications such as anesthetic and/or fluorescein drops, dilating drops, etc.). 2. Have active corneal pathology noted in the study eye at the screening visit. Active corneal pathology is defined as corneal pathology that is non stable, or greater than mild, or will compromise assessment of the safety or efficacy of treatment. 3. Are pregnant or nursing/lactating.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Cunningham, Derek N., O.D., P.A.
  • Collaborator
    • Bausch & Lomb Incorporated
  • Provider of Information About this Clinical Study
    • Principal Investigator: Derek N. Cunningham, PI – Cunningham, Derek N., O.D., P.A.
  • Overall Official(s)
    • Derek Cunningham, OD, Principal Investigator, Dell Laser Consultants

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.